Baliling, Jerlyn .
HRN: 13-48-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
CEFUROXIME 1.5GM (VIAL)
12/28/2024
12/29/2024
IV
1.5gm 2 Doses
Q8
Post Cs
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes